Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

Stargardt Disease

Rare Disease news

Latest Rare Disease News - Sept 26th to Oct 9th 2025

Watch Our Video Summary Capturing Top Rare Disease News from the Last Two……

Rare Disease news

Rare Diseases Weekly News - October 9th 2025

Rare Disease Update: GEMMABio RareTx, AAVantgarde Approvals, Neurotech RPDD,…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - August 28th 2025

🧬 This Week in Gene & Cell Therapy: Rocket Pharma, RMATs, CAR-T…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - August 21st 2025

🧬 This Week in Gene & Cell Therapy: Elevidys Safety Data, CAR-T Updates,…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - June 19th 2025

🧬 Gene & Cell Therapy Weekly Update: Parkinson's FDA clearance, $1.3B Heart…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Coverage
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

Tags

AAV MYO2 AAV vector Akero Therapeutics AMT-130 Apple Watch Hypertension ART5803 ASC35 ATM-negative mCRC Biopharma market trends BridgeBio cardiovascular risk factors Cas12 Cellectar Biosciences CEPI Coronary and Structural Interventions CT071 cutaneous T-cell lymphoma DESTINY-Breast09 deupirfenidone Diatech Diabetes Evkeeza FXa DOAC Global Burden of Disease GRADE Hanmi HM17321 heart failure congestion HLTH ISP-001 Kisunla metabolic disease Miltenyi Bioindustry mNSCLC Nature Immunology NHS fetal anomaly AI OGT OSENVELT personalized cancer vaccine Protalix Redx Pharma Salbutamol Servier TERN-601 TYK2 inhibitor UnitedHealthcare VELSIPITY

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

TAGS

AAV MYO2 AAV vector Akero Therapeutics AMT-130 Apple Watch Hypertension ART5803 ASC35 ATM-negative mCRC Biopharma market trends BridgeBio cardiovascular risk factors Cas12 Cellectar Biosciences CEPI Coronary and Structural Interventions CT071 cutaneous T-cell lymphoma DESTINY-Breast09 deupirfenidone Diatech Diabetes Evkeeza FXa DOAC Global Burden of Disease GRADE Hanmi HM17321 heart failure congestion HLTH ISP-001 Kisunla metabolic disease Miltenyi Bioindustry mNSCLC Nature Immunology NHS fetal anomaly AI OGT OSENVELT personalized cancer vaccine Protalix Redx Pharma Salbutamol Servier TERN-601 TYK2 inhibitor UnitedHealthcare VELSIPITY

Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy